Condition: ANCA Associated Vasculitis · Extramembranous Glomerulopathy · Nephrotic Syndrome, Minimal Change · Sponsor: Assistance Publique - Hôpitaux de Paris
The project is to explore in humans the hypothesis of the link between the alteration of tubulo-interstitial metabolism and the rate of deterioration of renal function by comparing various nephropathies.
This description comes directly from the study's public registry record.
Maxime BRUSSIEUX · +33 1 44 84 17 89 · maxime.brussieux@aphp.fr
Laura LE MAO · +33 1 56 09 54 97 · laura.le-mao@aphp.fr
Always discuss trial participation with your own doctor first.
| Georges-Pompidou European Hospital, AP-HP | Paris, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07010250